Johnson & Johnson saw its growth initiatives pay off in the third quarter and increased its earnings guidance for 2013.
The company had sales of $17.6 billion for the quarter, an increase of 3.1% as compared to the third quarter of 2012. Operational results increased 4.7% and the negative impact of currency was 1.6%. Domestic sales increased 1.7%. International sales increased 4.2%, reflecting operational growth of 7.1% and a negative currency impact of 2.9%.